168 related articles for article (PubMed ID: 11259468)
1. Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
Hemstreet GP; Yin S; Ma Z; Bonner RB; Bi W; Rao JY; Zang M; Zheng Q; Bane B; Asal N; Li G; Feng P; Hurst RE; Wang W
J Natl Cancer Inst; 2001 Mar; 93(6):427-36. PubMed ID: 11259468
[TBL] [Abstract][Full Text] [Related]
2. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
[TBL] [Abstract][Full Text] [Related]
3. Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
Bi W; Rao JY; Hemstreet GP; Fang P; Asal NR; Zang M; Min KW; Ma Z; Lee E; Li G
J Occup Med; 1993 Jan; 35(1):20-7. PubMed ID: 7678643
[TBL] [Abstract][Full Text] [Related]
4. Re: Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
Nersesyan AK
J Natl Cancer Inst; 2001 Oct; 93(19):1492-3. PubMed ID: 11584067
[No Abstract] [Full Text] [Related]
5. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.
Hayes RB; Bi W; Rothman N; Broly F; Caporaso N; Feng P; You X; Yin S; Woosley RL; Meyer UA
Carcinogenesis; 1993 Apr; 14(4):675-8. PubMed ID: 8472331
[TBL] [Abstract][Full Text] [Related]
6. [Expression of protein p53 in workers occupationally exposed to benzidine and bladder cancer patients.].
Shen CL; Xiang CQ; Zhang YY; Qin YQ; Liu CQ; Chen JG; Zhang SN
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):31-4. PubMed ID: 15748509
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences.
Guo WC; Lin GF; Chen JG; Golka K; Shen JH
Arch Toxicol; 2004 Aug; 78(8):425-9. PubMed ID: 15197537
[TBL] [Abstract][Full Text] [Related]
8. Mortality and incidence of bladder cancer in benzidine-exposed workers in China.
Bi W; Hayes RB; Feng P; Qi Y; You X; Zhen J; Zhang M; Qu B; Fu Z; Chen M
Am J Ind Med; 1992; 21(4):481-9. PubMed ID: 1580253
[TBL] [Abstract][Full Text] [Related]
9. GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells.
Ma Q; Lin G; Qin Y; Lu D; Golka K; Geller F; Chen J; Shen J
Pharmacogenetics; 2003 Jul; 13(7):409-15. PubMed ID: 12835616
[TBL] [Abstract][Full Text] [Related]
10. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK
Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747
[TBL] [Abstract][Full Text] [Related]
11. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers.
Rosenman KD; Reilly MJ
Am J Ind Med; 2004 Nov; 46(5):505-12. PubMed ID: 15490466
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic biomarker profiles for individual risk assessment and cancer detection (lessons from bladder cancer risk assessment in symptomatic patients and workers exposed to benzidine).
Hemstreet GP; Wang W
Front Biosci; 2004 Sep; 9():2671-9. PubMed ID: 15358590
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow.
Bulbulyan MA; Figgs LW; Zahm SH; Savitskaya T; Goldfarb A; Astashevsky S; Zaridze D
Int J Epidemiol; 1995 Apr; 24(2):266-75. PubMed ID: 7635585
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
15. Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai.
You XY; Chen JG; Hu YN
Br J Ind Med; 1990 Aug; 47(8):544-52. PubMed ID: 2393635
[TBL] [Abstract][Full Text] [Related]
16. Ongoing risk of bladder cancer among former workers at the last benzidine manufacturing facility in the USA.
Millerick-May ML; Wang L; Rice C; Rosenman KD
Occup Environ Med; 2021 Sep; 78(9):625-631. PubMed ID: 33972377
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
18. Filling the void: urinary markers for bladder cancer risk and diagnosis.
Gazdar AF; Czerniak B
J Natl Cancer Inst; 2001 Mar; 93(6):413-5. PubMed ID: 11259458
[No Abstract] [Full Text] [Related]
19. Detection of mutant p53 protein in workers occupationally exposed to benzidine.
Xiang CQ; Shen CL; Wu ZR; Qin YQ; Zhang YY; Liu CZ; Chen JG; Zhang SN
J Occup Health; 2007 Jul; 49(4):279-84. PubMed ID: 17690521
[TBL] [Abstract][Full Text] [Related]
20. Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts.
DeMarini DM; Brooks LR; Bhatnagar VK; Hayes RB; Eischen BT; Shelton ML; Zenser TV; Talaska G; Kashyap SK; Dosemeci M; Kashyap R; Parikh DJ; Lakshmi V; Hsu F; Davis BB; Jaeger M; Rothman N
Carcinogenesis; 1997 May; 18(5):981-8. PubMed ID: 9163684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
